Remodeling and reparation of the cardiovascular system

Karl Weber, Piero Anversa, Paul W. Armstrong, Christian G. Brilla, John C. Burnett, John M. Cruickshank, Richard B. Devereux, Thomas D. Giles, Niels Korsgaard, Carl V. Leier, Frederick A.O. Mendelsohn, Wolfgang H. Motz, Michael J. Mulvany, Bodo E. Strauer

Research output: Contribution to journalReview article

288 Citations (Scopus)

Abstract

Growth or altered metabolism of nonmyocyte cells (cardiac fibroblasts, vascular smooth muscle and endothelial cells) alters myocardial and vascular structure (remodeling) and function. However, the precise roles of circulating and locally generated factors such as angiotensin II, aldosterone and endothelin that regulate growth and metabolism of nonmyocyte cells have yet to be fully elucidated. Trials of pharmacologic therapy aimed at preventing structural remodeling and repairing altered myocardial structure to or toward normal in the setting of hypertension, heart failure and diabetes are reviewed. It is proposed that these are therapeutic goals that may reduce cardiovascular morbidity and mortality. Although this hypothesis remains unproved the primary goal of therapy should be to preserve or restore tissue structure and function.

Original languageEnglish (US)
Pages (from-to)3-16
Number of pages14
JournalJournal of the American College of Cardiology
Volume20
Issue number1
DOIs
StatePublished - Jan 1 1992

Fingerprint

Cardiovascular System
Endothelins
Growth
Aldosterone
Vascular Smooth Muscle
Angiotensin II
Smooth Muscle Myocytes
Therapeutics
Endothelial Cells
Heart Failure
Fibroblasts
Hypertension
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Weber, K., Anversa, P., Armstrong, P. W., Brilla, C. G., Burnett, J. C., Cruickshank, J. M., ... Strauer, B. E. (1992). Remodeling and reparation of the cardiovascular system. Journal of the American College of Cardiology, 20(1), 3-16. https://doi.org/10.1016/0735-1097(92)90130-F

Remodeling and reparation of the cardiovascular system. / Weber, Karl; Anversa, Piero; Armstrong, Paul W.; Brilla, Christian G.; Burnett, John C.; Cruickshank, John M.; Devereux, Richard B.; Giles, Thomas D.; Korsgaard, Niels; Leier, Carl V.; Mendelsohn, Frederick A.O.; Motz, Wolfgang H.; Mulvany, Michael J.; Strauer, Bodo E.

In: Journal of the American College of Cardiology, Vol. 20, No. 1, 01.01.1992, p. 3-16.

Research output: Contribution to journalReview article

Weber, K, Anversa, P, Armstrong, PW, Brilla, CG, Burnett, JC, Cruickshank, JM, Devereux, RB, Giles, TD, Korsgaard, N, Leier, CV, Mendelsohn, FAO, Motz, WH, Mulvany, MJ & Strauer, BE 1992, 'Remodeling and reparation of the cardiovascular system', Journal of the American College of Cardiology, vol. 20, no. 1, pp. 3-16. https://doi.org/10.1016/0735-1097(92)90130-F
Weber, Karl ; Anversa, Piero ; Armstrong, Paul W. ; Brilla, Christian G. ; Burnett, John C. ; Cruickshank, John M. ; Devereux, Richard B. ; Giles, Thomas D. ; Korsgaard, Niels ; Leier, Carl V. ; Mendelsohn, Frederick A.O. ; Motz, Wolfgang H. ; Mulvany, Michael J. ; Strauer, Bodo E. / Remodeling and reparation of the cardiovascular system. In: Journal of the American College of Cardiology. 1992 ; Vol. 20, No. 1. pp. 3-16.
@article{d9040ae715ce446e988b23a5737aeed0,
title = "Remodeling and reparation of the cardiovascular system",
abstract = "Growth or altered metabolism of nonmyocyte cells (cardiac fibroblasts, vascular smooth muscle and endothelial cells) alters myocardial and vascular structure (remodeling) and function. However, the precise roles of circulating and locally generated factors such as angiotensin II, aldosterone and endothelin that regulate growth and metabolism of nonmyocyte cells have yet to be fully elucidated. Trials of pharmacologic therapy aimed at preventing structural remodeling and repairing altered myocardial structure to or toward normal in the setting of hypertension, heart failure and diabetes are reviewed. It is proposed that these are therapeutic goals that may reduce cardiovascular morbidity and mortality. Although this hypothesis remains unproved the primary goal of therapy should be to preserve or restore tissue structure and function.",
author = "Karl Weber and Piero Anversa and Armstrong, {Paul W.} and Brilla, {Christian G.} and Burnett, {John C.} and Cruickshank, {John M.} and Devereux, {Richard B.} and Giles, {Thomas D.} and Niels Korsgaard and Leier, {Carl V.} and Mendelsohn, {Frederick A.O.} and Motz, {Wolfgang H.} and Mulvany, {Michael J.} and Strauer, {Bodo E.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0735-1097(92)90130-F",
language = "English (US)",
volume = "20",
pages = "3--16",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Remodeling and reparation of the cardiovascular system

AU - Weber, Karl

AU - Anversa, Piero

AU - Armstrong, Paul W.

AU - Brilla, Christian G.

AU - Burnett, John C.

AU - Cruickshank, John M.

AU - Devereux, Richard B.

AU - Giles, Thomas D.

AU - Korsgaard, Niels

AU - Leier, Carl V.

AU - Mendelsohn, Frederick A.O.

AU - Motz, Wolfgang H.

AU - Mulvany, Michael J.

AU - Strauer, Bodo E.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Growth or altered metabolism of nonmyocyte cells (cardiac fibroblasts, vascular smooth muscle and endothelial cells) alters myocardial and vascular structure (remodeling) and function. However, the precise roles of circulating and locally generated factors such as angiotensin II, aldosterone and endothelin that regulate growth and metabolism of nonmyocyte cells have yet to be fully elucidated. Trials of pharmacologic therapy aimed at preventing structural remodeling and repairing altered myocardial structure to or toward normal in the setting of hypertension, heart failure and diabetes are reviewed. It is proposed that these are therapeutic goals that may reduce cardiovascular morbidity and mortality. Although this hypothesis remains unproved the primary goal of therapy should be to preserve or restore tissue structure and function.

AB - Growth or altered metabolism of nonmyocyte cells (cardiac fibroblasts, vascular smooth muscle and endothelial cells) alters myocardial and vascular structure (remodeling) and function. However, the precise roles of circulating and locally generated factors such as angiotensin II, aldosterone and endothelin that regulate growth and metabolism of nonmyocyte cells have yet to be fully elucidated. Trials of pharmacologic therapy aimed at preventing structural remodeling and repairing altered myocardial structure to or toward normal in the setting of hypertension, heart failure and diabetes are reviewed. It is proposed that these are therapeutic goals that may reduce cardiovascular morbidity and mortality. Although this hypothesis remains unproved the primary goal of therapy should be to preserve or restore tissue structure and function.

UR - http://www.scopus.com/inward/record.url?scp=0026719577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026719577&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(92)90130-F

DO - 10.1016/0735-1097(92)90130-F

M3 - Review article

VL - 20

SP - 3

EP - 16

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 1

ER -